Status : Published Published On : Jan, 2024 Report Code : VRSME9023 Industry : Semiconductor & Electronics Available Format : Page : 162

Global Biosensors Market - Analysis and Forecast (2025-2030)

Industry Insights by Type (Wearable, Non-wearable), By Technology (Electrochemical, Optical, Thermal, Piezoelectric, Nanomechanical, Others), by Application (Point of Care, Home Diagnostics, Research Lab, Biodefense, Environmental Monitoring, Food & Beverages)

Industry Overview

The market for biosensors stood at $24.4 billion in 2023 and it is expected to reach $38.0 billion in 2030, advancing at a CAGR of 8% during the forecast period which is 2025-2030. The growing healthcare applications of biosensors, the rising demand for small diagnostic tools, the increasing number of diabetic patients, and the ongoing technological improvements are the main drivers of the market growth worldwide. 

Biosensors Market

Market Segmentation

Insight by Type

The global biosensors market is divided into wearable and non-wearable categories, based on type. The non-wearable category accounted for a larger market share in 2019. This is due to the high prevalence of chronic diseases, including cancer, diabetes, and other ailments, which increase the demand for traditional techniques of diagnosis and detection. These traditional techniques include biosensors, which are frequently employed in hospitals and laboratories for the detection of blood sugar levels or the analysis of gas levels in the blood. Non-wearable biosensors' high efficacy and precision combined with ongoing product improvement are projected to have a beneficial effect on the market growth in this category throughout the course of the forecast period.

However, due to the rising awareness of healthy lifestyles, the market for wearable biosensors is anticipated to expand at a higher rate throughout the forecast period. Due to adults' declining physical activity, which contributes to increased weight and hormonal diseases, the adoption rate of wearable biosensors is increasing in both developed and developing countries.

Insight by Technology

The biosensors market is divided into electrochemical, thermal, nanomechanical, optical, piezoelectric, and others, based on technology. Among these, the electrochemical category dominates the market. The growing need for electrochemical biosensors in food analysis and disease diagnostics is the primary factor propelling the growth of the electrochemical biosensors market. Moreover, due to the rise in diabetes patients, the demand for glucometers based on electrochemical biosensor technology is increasing. Additionally, the surging prevalence of chronic diseases is projected to increase the demand for electrochemical biosensors, which facilitate precise diagnosis.

Global Biosensors Market Report Coverage

Report Metric


Historical Period

2018 - 2023

Base Year Considered


Forecast Period

2025 - 2030

Market Size in 2023

U.S.D.  24.4 Billion

Revenue Forecast in 2030

U.S.D.  38.0 Billion

Growth Rate


Segments Covered in the Report

By Type, By Technology.

Report Scope

Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Impact of COVID-19; Companies’ Strategic Developments; Market Share Analysis of Key Players; Company Profiling

Regions Covered in the Report

North America, Europe, Asia-Pacific, Middle East, and the Rest of the World

Industry Dynamics

Growth Drivers

The various healthcare applications of biosensors, the rising demand for small diagnostic tools, the increasing number of diabetic patients, and ongoing technical improvements are the main drivers propelling the growth of the worldwide biosensors market.

For instance, according to the WHO, there were 422 million cases of diabetes in 2014. Additionally, according to the International Diabetes Federation (IDF), the number of adults with diabetes worldwide is projected to rise to 629 million by the year 2045, from 425 million in 2017. The growing public awareness of diabetes self-management encourages the integration of cutting-edge technology in glucometers, which propels the growth of the biosensors market.


The expensive nature of biosensor development and the delayed rate of commercialization could restrain the expansion of the world biosensors market.


The market offers several opportunities to players, due to the following reasons:

  • Emerging markets in developing countries
  • Lucrative development potential in the food business, environmental monitoring, and biodefense

Geographic Overview

Geographically, North America leads the biosensors market. The preference for biosensors is predicted to expand in the region, as a result of the rising incidence of chronic diseases like cancer, diabetes, and problems linked to obesity. The need for biosensors in the area ought to be stimulated by increasing investment in R&D efforts to meet changing and expanding client demand. Additionally, the growing aging population, increased government financing, and technical advancements are all driving the North American biosensors market forward. For instance, the U.S. Census Bureau estimated that there were around 43.1 million Americans aged 65 years and over in 2012, and this number is projected to increase to 83.7 million by 2050.

On the other hand, the APAC market is expected to witness the fastest growth in the coming years, globally. This can be due to its dense population, growth in the aging population, high prevalence of chronic diseases, and improvement in the healthcare system in the region.

Competitive Insight

Dupont provides trusted biosensor products that are utilized in crucial patient care. It produces several screen-printed inks for use in biosensors using metallurgical and organic processes. These materials were created specifically for sensors used in environmental, food, diagnostics, patient monitoring, and medicine delivery applications.

In order to improve outcomes for patients with diabetes, hypertension, heart disease, and other chronic conditions, Medtronics is moving toward sensor-based solutions. For cardiac resynchronization therapy (CRT) and implantable cardiac defibrillators (ICDs) devices, Medtronics created one of the first sensing technologies that is used to track predictive data for cardiac patients and warn them of any worsening fluid in the lungs that could result in hospitalization.

Some of the major players operating in the global biosensors market are Roche Diagnostics, DowDuPont, Johnson & Johnson, Siemens Healthcare, Abbott Laboratories, Nova Biomedical Corp., LifeSensors Inc., ACON Laboratories Inc., Biacore., Medtronic Inc., and Thermo-Fisher Scientific.

Forecast Parameters

  • Identifying variables and establishing market impact.
  • Establishing market trends regionally.
  • Analyzing opportunities and market penetration rates by understanding product commercialization, and regional expansion.
  • Analyzing demand and supply trends and changes in industry dynamics to establish future growth.
  • Analyzing sustainability strategies adhered to by market participants in an attempt to determine the future course of the market.
  • Analyzing historical market trends and super-imposing them on the current and future variables to determine year-on-year trends.
  • Understanding adoption, development, distribution, and regulatory framework.

Data Validation

  • Estimated and forecasted data was validated by industry experts.
  • Apart from industry experts, data triangulation methods were used for validation.
  • The bottom-and top-down approach has been used for the estimation and forecast of market data, whereas the top-down approach was used for validation.
  • Demand, as well as supply side surveys, were conducted in order to understand the industry dynamics and data validation.

Research Phases

Biosensors Market Research Phase

Primary Research

VynZ Research conducts extensive primary research to understand the market dynamics, validate market data, and have key opinions from industry experts. The key profiles approached within the industry include the CEO, CFO, CTO, President, Vice President, Product Managers, Regional Heads, and Others. Also, end user surveys comprising of consumers are also conducted to understand consumer behavior.

Biosensors Market Size

Source: VynZ Research

Biosensors Market Analysis

Source: VynZ Research

The Biosensors Market report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2025–2030.

Segments Covered in the Report

  • By Type
    • Wearable
    • Non-Wearable
  • By Technology
    • Electrochemical
    • Thermal
    • Nanomechanical
    • Optical
    • Piezoelectric
    • Others

Region Covered in the Report

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World (RoW)
    • Brazil
    • Saudi Arabia
    • South Africa
    • U.A.E.
    • Other Countries

Frequently Asked Questions

The North America region holds the highest potential for the Biosensors Market growth.
The global Biosensors Market is projected to grow at approximately 13.6% CAGR during the assessment period (2025-2030).
The segments of the Biosensors Market include Type, Technology, Application, and Region
DowDuPont, Roche Diagnostics, Johnson & Johnson, Abbott Laboratories, Siemens Healthcare, Nova Biomedical Corp., ACON Laboratories, Inc., LifeSensors Inc., Medtronic Inc., Biacore., and Thermo-Fisher Scientific are some notable players of the Biosensors Market.
The global biosensors market was valued at USD 41.2 billion in 2023 and is predicted to reach USD 83.79 billion by 2030.

Place an order

Research Methodology

  •  Desk Research / Pilot Interviews
  •  Build Market Size Model
  •  Research and Analysis
  •  Final Deliverabvle